These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28902357)

  • 1. Expression of Wnt3a in hepatocellular carcinoma and its effects on cell cycle and metastasis.
    Lu C; He Y; Duan J; Yang Y; Zhong C; Zhang J; Liao W; Huang X; Zhu R; Li M
    Int J Oncol; 2017 Oct; 51(4):1135-1145. PubMed ID: 28902357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.
    Du X; Fan W; Chen Y
    Gene; 2018 May; 657():30-38. PubMed ID: 29505836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
    Geng D; Zhao W; Feng Y; Liu J
    Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
    Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
    Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
    Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
    Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZNF300 promotes proliferation and migration of hepatocellular carcinoma by upregulating c-MYC gene expression.
    Xiang W; Ni J; Dong L; Zhu G
    Clin Res Hepatol Gastroenterol; 2024 Aug; 48(7):102415. PubMed ID: 39018766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear EpICD expression and its role in hepatocellular carcinoma.
    Park SY; Bae JS; Cha EJ; Chu HH; Sohn JS; Moon WS
    Oncol Rep; 2016 Jul; 36(1):197-204. PubMed ID: 27176150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
    Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
    Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9.
    Liu J; Wen X; Liu B; Zhang Q; Zhang J; Miao H; Zhu R
    Mol Med Rep; 2016 Mar; 13(3):2401-8. PubMed ID: 26847170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A c-Myc/miR-17-5p feedback loop regulates metastasis and invasion of hepatocellular carcinoma.
    Liu D; Dong L; Liu Y; Wen D; Gao D; Sun H; Fan J; Wu W
    Tumour Biol; 2016 Apr; 37(4):5039-47. PubMed ID: 26546431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells.
    Yang Y; Li M; Chang S; Wang L; Song T; Gao L; Hu L; Li Z; Liu L; Yao J; Huang C
    Mol Med Rep; 2014 Nov; 10(5):2643-8. PubMed ID: 25174704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of Notch1 inhibits the invasion of human hepatocellular carcinoma HepG2 and MHCC97H cells through the regulation of PTEN and FAK.
    Hu YJ; Li HY; Qiu KJ; Li DC; Zhou JH; Hu YH; Zhang FM
    Int J Mol Med; 2014 Oct; 34(4):1081-6. PubMed ID: 25110169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells.
    Chen J; Li X; Cheng Q; Ning D; Ma J; Zhang ZP; Chen XP; Jiang L
    J Cell Biochem; 2018 Feb; 119(2):2368-2380. PubMed ID: 28885717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-regulated protein 94 mediates metastasis by CCT8 and the JNK pathway in hepatocellular carcinoma.
    Wei PL; Huang CY; Tai CJ; Batzorig U; Cheng WL; Hunag MT; Chang YJ
    Tumour Biol; 2016 Jun; 37(6):8219-27. PubMed ID: 26718209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2.
    Chen Y; Lin C; Liu Y; Jiang Y
    Tumour Biol; 2016 Apr; 37(4):4399-408. PubMed ID: 26499944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.